Surf Bio

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Latest funding

$16M Seed · April 12, 2022

Acquired by HHalozyme Therapeutics on December 1, 2025 · fiercepharma.com.

Website: surf.bio.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Oncology, Pharmaceutical, Therapeutics.

Stage: Seed.

Based in: Palo Alto, United States.

Founded: 2021.

Last round: Apr 12, 2022 · 1,675 days ago.

Headcount: 1–10 employees.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredNov 27, 2020 (5 years old)

TIMELINE · MONEY RAISED

Raised $16M in 1 sourced round·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

December 1, 2025
Acquired by HHalozyme Therapeutics
Source: fiercepharma.com
April 12, 2022
Seed · $16M
BBreakout Ventures (lead), PPerceptive Advisors (lead)
Source: finsmes.com
November 27, 2020
Website created

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/surf-bio (get a free API key).